A phase I study of bevacizumab (BV) plus ABT-510 in patients with advanced solid tumors

被引：0
|
作者：
Uronis, H. E. [1 ]
Bendell, J. [1 ]
Blobe, G. [1 ]
Morse, M. [1 ]
Geier, D. [1 ]
Nixon, A. [1 ]
Howard, L. [1 ]
Evans, D. [1 ]
Li, H. [1 ]
Hurwitz, H. [1 ]
机构：
[1] Duke Univ, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3541
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I study with paclitaxel in combination with sorafenib and bevacizumab in patients with locally advanced or metastatic solid tumors
    Schultheis, B.
    Neumann, H.
    Roy, R.
    Heuer, V
    Kummer, G.
    Strumberg, D.
    ONKOLOGIE, 2011, 34 : 110 - 110
  • [42] A Phase 1 Trial of ABT-510 Concurrent With Standard Chemoradiation for Patients With Newly Diagnosed Glioblastoma
    Nabors, Louis B.
    Fiveash, John B.
    Markert, James M.
    Kekan, Manasi S.
    Gillespie, George Y.
    Huang, Zhi
    Johnson, Martin J.
    Meleth, Sreelatha
    Kuo, Huichien
    Gladson, Candece L.
    Fathallah-Shaykh, Hassan M.
    ARCHIVES OF NEUROLOGY, 2010, 67 (03) : 313 - 319
  • [43] A phase I dose escalation study of sunitinib plus capecitabine in patients with advanced solid tumors
    Sweeney, C.
    Verschraegen, C.
    Chiorean, G.
    Lee, F.
    Jones, S.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H., III
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma
    Markovic, Svetomir N.
    Suman, Vera J.
    Rao, Ravi A.
    Ingle, James N.
    Kaur, Judith S.
    Erickson, Lori A.
    Pitot, Henry C.
    Croghan, Gary A.
    McWilliams, Robert R.
    Merchan, Jaime
    Kottschade, Lisa A.
    Nevala, Wendy K.
    Uhl, Cindy B.
    Allred, Jacob
    Creagan, Edward T.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (03): : 303 - 309
  • [45] Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors
    Denlinger, Crystal S.
    Blanchard, Rebecca
    Xu, Lu
    Bernaards, Coen
    Litwin, Samuel
    Spittle, Cynthia
    Berg, Daniel J.
    McLaughlin, Susan
    Redlinger, Maryann
    Dorr, Andrew
    Hambleton, Julie
    Holden, Scott
    Kearns, Anne
    Kenkare-Mitra, Sara
    Lum, Bert
    Meropol, Neal J.
    O'Dwyer, Peter J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 97 - 105
  • [46] Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors
    Crystal S. Denlinger
    Rebecca Blanchard
    Lu Xu
    Coen Bernaards
    Samuel Litwin
    Cynthia Spittle
    Daniel J. Berg
    Susan McLaughlin
    Maryann Redlinger
    Andrew Dorr
    Julie Hambleton
    Scott Holden
    Anne Kearns
    Sara Kenkare-Mitra
    Bert Lum
    Neal J. Meropol
    Peter J. O’Dwyer
    Cancer Chemotherapy and Pharmacology, 2009, 65 : 97 - 105
  • [47] Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
    Rangwala, Fatima A.
    Bendell, Johanna C.
    Kozloff, Mark
    Arrowood, Christy
    Meadows, Jennifer
    Tourt-Uhlig, Sandra Ellen
    Murphy, Jennifer
    Meadows, Kellen
    Morse, Michael
    Uronis, Hope Elizabeth
    Hsu, Shiaowen David
    Zafar, Yousuf
    Hurwitz, Herbert
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [48] A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors
    Liu, Stephen V.
    Groshen, Susan G.
    Kelly, Karen
    Reckamp, Karen L.
    Belani, Chandra
    Synold, Timothy W.
    Goldkorn, Amir
    Gitlitz, Barbara J.
    Cristea, Mihaela C.
    Gong, I-Yeh
    Semrad, Thomas J.
    Xu, Yucheng
    Xu, Tong
    Koczywas, Marianna
    Gandara, David R.
    Newman, Edward M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (04) : 723 - 732
  • [49] A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors
    Stephen V. Liu
    Susan G. Groshen
    Karen Kelly
    Karen L. Reckamp
    Chandra Belani
    Timothy W. Synold
    Amir Goldkorn
    Barbara J. Gitlitz
    Mihaela C. Cristea
    I-Yeh Gong
    Thomas J. Semrad
    Yucheng Xu
    Tong Xu
    Marianna Koczywas
    David R. Gandara
    Edward M. Newman
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 723 - 732
  • [50] Phase I study of camrelizumab in patients with advanced solid tumors
    Yuxiang Ma
    Jiaxin Cao
    Yang Zhang
    Qianwen Liu
    Wenfeng Fang
    Yunpeng Yang
    Yuanyuan Zhao
    Qing Yang
    Hongyun Zhao
    Li Zhang
    Signal Transduction and Targeted Therapy, 8
12345